Macquarie Group’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-20,000	Closed	-$101K	–	1579
2014 Q3	$101K	Sell	20,000 -60,000	-75%	-$303K	﹤0.01%	1436
2014 Q2	$1.11M	Sell	80,000 -51,500	-39%	-$711K	﹤0.01%	1183
2014 Q1	$2.01M	Buy	+131,500	New	+$2.01M	﹤0.01%	1014